The Dixie Group, Inc.
The Dixie Group, Inc. (DXYN) Stock Competitors & Peer Comparison
See (DXYN) competitors and their performances in Stock Market.
Peer Comparison Table: Apparel - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DXYN | $0.43 | +0.00% | 6M | -0.57 | -$0.76 | N/A |
| RL | $339.24 | +2.57% | 20.6B | 23.11 | $14.68 | +1.08% |
| GIL | $58.65 | -0.02% | 9B | 22.82 | $2.57 | +1.53% |
| LEVI | $18.52 | +3.41% | 7.3B | 14.70 | $1.26 | +3.06% |
| VFC | $16.03 | +0.44% | 6.3B | 28.12 | $0.57 | +2.27% |
| KTB | $67.28 | -0.31% | 3.7B | 16.63 | $4.05 | +3.10% |
| PVH | $62.37 | +2.46% | 3B | 9.54 | $6.54 | +0.25% |
| COLM | $55.02 | -0.42% | 3B | 16.98 | $3.24 | +2.17% |
| UAA | $6.35 | -2.16% | 2.7B | -5.20 | -$1.22 | N/A |
| UA | $6.19 | -1.20% | 2.6B | -5.07 | -$1.22 | N/A |
Stock Comparison
DXYN vs RL Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, RL has a market cap of 20.6B. Regarding current trading prices, DXYN is priced at $0.43, while RL trades at $339.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas RL's P/E ratio is 23.11. In terms of profitability, DXYN's ROE is -0.81%, compared to RL's ROE of +0.35%. Regarding short-term risk, DXYN is less volatile compared to RL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check RL's competition here
DXYN vs GIL Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, GIL has a market cap of 9B. Regarding current trading prices, DXYN is priced at $0.43, while GIL trades at $58.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas GIL's P/E ratio is 22.82. In terms of profitability, DXYN's ROE is -0.81%, compared to GIL's ROE of +0.20%. Regarding short-term risk, DXYN is less volatile compared to GIL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GIL's competition here
DXYN vs LEVI Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, LEVI has a market cap of 7.3B. Regarding current trading prices, DXYN is priced at $0.43, while LEVI trades at $18.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas LEVI's P/E ratio is 14.70. In terms of profitability, DXYN's ROE is -0.81%, compared to LEVI's ROE of +0.27%. Regarding short-term risk, DXYN is less volatile compared to LEVI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LEVI's competition here
DXYN vs VFC Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, VFC has a market cap of 6.3B. Regarding current trading prices, DXYN is priced at $0.43, while VFC trades at $16.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas VFC's P/E ratio is 28.12. In terms of profitability, DXYN's ROE is -0.81%, compared to VFC's ROE of +0.15%. Regarding short-term risk, DXYN is less volatile compared to VFC. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check VFC's competition here
DXYN vs KTB Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, KTB has a market cap of 3.7B. Regarding current trading prices, DXYN is priced at $0.43, while KTB trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas KTB's P/E ratio is 16.63. In terms of profitability, DXYN's ROE is -0.81%, compared to KTB's ROE of +0.45%. Regarding short-term risk, DXYN is less volatile compared to KTB. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check KTB's competition here
DXYN vs PVH Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, PVH has a market cap of 3B. Regarding current trading prices, DXYN is priced at $0.43, while PVH trades at $62.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas PVH's P/E ratio is 9.54. In terms of profitability, DXYN's ROE is -0.81%, compared to PVH's ROE of +0.07%. Regarding short-term risk, DXYN is less volatile compared to PVH. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check PVH's competition here
DXYN vs COLM Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, COLM has a market cap of 3B. Regarding current trading prices, DXYN is priced at $0.43, while COLM trades at $55.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas COLM's P/E ratio is 16.98. In terms of profitability, DXYN's ROE is -0.81%, compared to COLM's ROE of +0.11%. Regarding short-term risk, DXYN is less volatile compared to COLM. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check COLM's competition here
DXYN vs UAA Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, UAA has a market cap of 2.7B. Regarding current trading prices, DXYN is priced at $0.43, while UAA trades at $6.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas UAA's P/E ratio is -5.20. In terms of profitability, DXYN's ROE is -0.81%, compared to UAA's ROE of -0.29%. Regarding short-term risk, DXYN is less volatile compared to UAA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UAA's competition here
DXYN vs UA Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, UA has a market cap of 2.6B. Regarding current trading prices, DXYN is priced at $0.43, while UA trades at $6.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas UA's P/E ratio is -5.07. In terms of profitability, DXYN's ROE is -0.81%, compared to UA's ROE of -0.29%. Regarding short-term risk, DXYN is less volatile compared to UA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UA's competition here
DXYN vs ZGN Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, ZGN has a market cap of 2.5B. Regarding current trading prices, DXYN is priced at $0.43, while ZGN trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas ZGN's P/E ratio is 23.00. In terms of profitability, DXYN's ROE is -0.81%, compared to ZGN's ROE of +0.11%. Regarding short-term risk, DXYN is less volatile compared to ZGN. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check ZGN's competition here
DXYN vs FIGS Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, FIGS has a market cap of 2.5B. Regarding current trading prices, DXYN is priced at $0.43, while FIGS trades at $14.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas FIGS's P/E ratio is 78.37. In terms of profitability, DXYN's ROE is -0.81%, compared to FIGS's ROE of +0.08%. Regarding short-term risk, DXYN is less volatile compared to FIGS. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check FIGS's competition here
DXYN vs HBI Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, HBI has a market cap of 2.3B. Regarding current trading prices, DXYN is priced at $0.43, while HBI trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas HBI's P/E ratio is 5.53. In terms of profitability, DXYN's ROE is -0.81%, compared to HBI's ROE of +1.91%. Regarding short-term risk, DXYN is less volatile compared to HBI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check HBI's competition here
DXYN vs AIN Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, AIN has a market cap of 1.6B. Regarding current trading prices, DXYN is priced at $0.43, while AIN trades at $54.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas AIN's P/E ratio is -27.88. In terms of profitability, DXYN's ROE is -0.81%, compared to AIN's ROE of -0.07%. Regarding short-term risk, DXYN is less volatile compared to AIN. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check AIN's competition here
DXYN vs GIII Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, GIII has a market cap of 1.1B. Regarding current trading prices, DXYN is priced at $0.43, while GIII trades at $25.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas GIII's P/E ratio is 7.90. In terms of profitability, DXYN's ROE is -0.81%, compared to GIII's ROE of +0.04%. Regarding short-term risk, DXYN is less volatile compared to GIII. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GIII's competition here
DXYN vs GOOS Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, GOOS has a market cap of 1B. Regarding current trading prices, DXYN is priced at $0.43, while GOOS trades at $10.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas GOOS's P/E ratio is 67.44. In terms of profitability, DXYN's ROE is -0.81%, compared to GOOS's ROE of +0.04%. Regarding short-term risk, DXYN is less volatile compared to GOOS. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check GOOS's competition here
DXYN vs OXM Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, OXM has a market cap of 538M. Regarding current trading prices, DXYN is priced at $0.43, while OXM trades at $36.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas OXM's P/E ratio is -139.10. In terms of profitability, DXYN's ROE is -0.81%, compared to OXM's ROE of -0.00%. Regarding short-term risk, DXYN is less volatile compared to OXM. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check OXM's competition here
DXYN vs SGC Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, SGC has a market cap of 161M. Regarding current trading prices, DXYN is priced at $0.43, while SGC trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas SGC's P/E ratio is 22.28. In terms of profitability, DXYN's ROE is -0.81%, compared to SGC's ROE of +0.04%. Regarding short-term risk, DXYN is less volatile compared to SGC. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check SGC's competition here
DXYN vs LAKE Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, LAKE has a market cap of 85.2M. Regarding current trading prices, DXYN is priced at $0.43, while LAKE trades at $8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas LAKE's P/E ratio is -1.94. In terms of profitability, DXYN's ROE is -0.81%, compared to LAKE's ROE of -0.26%. Regarding short-term risk, DXYN is less volatile compared to LAKE. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LAKE's competition here
DXYN vs FFFZ Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, FFFZ has a market cap of 68.8M. Regarding current trading prices, DXYN is priced at $0.43, while FFFZ trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas FFFZ's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.81%, compared to FFFZ's ROE of N/A. Regarding short-term risk, DXYN and FFFZ have similar daily volatility (0.00).Check FFFZ's competition here
DXYN vs UFI Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, UFI has a market cap of 68.2M. Regarding current trading prices, DXYN is priced at $0.43, while UFI trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas UFI's P/E ratio is -3.01. In terms of profitability, DXYN's ROE is -0.81%, compared to UFI's ROE of -0.23%. Regarding short-term risk, DXYN is less volatile compared to UFI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check UFI's competition here
DXYN vs CULP Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, CULP has a market cap of 41M. Regarding current trading prices, DXYN is priced at $0.43, while CULP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas CULP's P/E ratio is -3.77. In terms of profitability, DXYN's ROE is -0.81%, compared to CULP's ROE of -0.10%. Regarding short-term risk, DXYN is less volatile compared to CULP. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check CULP's competition here
DXYN vs JRSH Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, JRSH has a market cap of 38.7M. Regarding current trading prices, DXYN is priced at $0.43, while JRSH trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas JRSH's P/E ratio is 21.79. In terms of profitability, DXYN's ROE is -0.81%, compared to JRSH's ROE of +0.03%. Regarding short-term risk, DXYN is less volatile compared to JRSH. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JRSH's competition here
DXYN vs VNCE Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, VNCE has a market cap of 32M. Regarding current trading prices, DXYN is priced at $0.43, while VNCE trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas VNCE's P/E ratio is -1.62. In terms of profitability, DXYN's ROE is -0.81%, compared to VNCE's ROE of -0.40%. Regarding short-term risk, DXYN is less volatile compared to VNCE. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check VNCE's competition here
DXYN vs NCI Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, NCI has a market cap of 25.3M. Regarding current trading prices, DXYN is priced at $0.43, while NCI trades at $6.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas NCI's P/E ratio is 22.25. In terms of profitability, DXYN's ROE is -0.81%, compared to NCI's ROE of +0.02%. Regarding short-term risk, DXYN is less volatile compared to NCI. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check NCI's competition here
DXYN vs JL Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, JL has a market cap of 18.9M. Regarding current trading prices, DXYN is priced at $0.43, while JL trades at $4.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas JL's P/E ratio is 7.40. In terms of profitability, DXYN's ROE is -0.81%, compared to JL's ROE of +0.31%. Regarding short-term risk, DXYN is less volatile compared to JL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JL's competition here
DXYN vs LLL Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, LLL has a market cap of 10.8M. Regarding current trading prices, DXYN is priced at $0.43, while LLL trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas LLL's P/E ratio is -0.10. In terms of profitability, DXYN's ROE is -0.81%, compared to LLL's ROE of +0.22%. Regarding short-term risk, DXYN is less volatile compared to LLL. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check LLL's competition here
DXYN vs PMNT Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, PMNT has a market cap of 8.1M. Regarding current trading prices, DXYN is priced at $0.43, while PMNT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas PMNT's P/E ratio is -0.35. In terms of profitability, DXYN's ROE is -0.81%, compared to PMNT's ROE of -10.56%. Regarding short-term risk, Volatility data is not available for a full comparison. DXYN has daily volatility of 0.00 and PMNT has daily volatility of N/A.Check PMNT's competition here
DXYN vs XELB Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, XELB has a market cap of 6.2M. Regarding current trading prices, DXYN is priced at $0.43, while XELB trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas XELB's P/E ratio is -0.16. In terms of profitability, DXYN's ROE is -0.81%, compared to XELB's ROE of -0.86%. Regarding short-term risk, DXYN is less volatile compared to XELB. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check XELB's competition here
DXYN vs JXJT Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, JXJT has a market cap of 4.9M. Regarding current trading prices, DXYN is priced at $0.43, while JXJT trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas JXJT's P/E ratio is 1.47. In terms of profitability, DXYN's ROE is -0.81%, compared to JXJT's ROE of +0.22%. Regarding short-term risk, DXYN is less volatile compared to JXJT. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check JXJT's competition here
DXYN vs DLA Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, DLA has a market cap of 4.1M. Regarding current trading prices, DXYN is priced at $0.43, while DLA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas DLA's P/E ratio is -0.06. In terms of profitability, DXYN's ROE is -0.81%, compared to DLA's ROE of -0.20%. Regarding short-term risk, DXYN is less volatile compared to DLA. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check DLA's competition here
DXYN vs SQBG Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, SQBG has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.43, while SQBG trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas SQBG's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.81%, compared to SQBG's ROE of -1.42%. Regarding short-term risk, DXYN is less volatile compared to SQBG. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check SQBG's competition here
DXYN vs PERY Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, PERY has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.43, while PERY trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas PERY's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.81%, compared to PERY's ROE of +0.15%. Regarding short-term risk, DXYN and PERY have similar daily volatility (0.00).Check PERY's competition here
DXYN vs KBSF Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, KBSF has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.43, while KBSF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas KBSF's P/E ratio is -1.46. In terms of profitability, DXYN's ROE is -0.81%, compared to KBSF's ROE of -0.10%. Regarding short-term risk, DXYN is less volatile compared to KBSF. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check KBSF's competition here
DXYN vs EVK Comparison March 2026
DXYN plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DXYN stands at 6M. In comparison, EVK has a market cap of 0. Regarding current trading prices, DXYN is priced at $0.43, while EVK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DXYN currently has a P/E ratio of -0.57, whereas EVK's P/E ratio is N/A. In terms of profitability, DXYN's ROE is -0.81%, compared to EVK's ROE of -0.00%. Regarding short-term risk, DXYN is less volatile compared to EVK. This indicates potentially lower risk in terms of short-term price fluctuations for DXYN.Check EVK's competition here